On May 4, 2026, Brazil’s National Health Surveillance Agency (ANVISA) launched the ‘Natural Ingredients Fast Track’ program — a regulatory acceleration initiative targeting plant extracts, natural flavors, and food-grade enzymes that hold OECD GLP certification. This development significantly shortens the registration timeline for such natural ingredients from an average of 120 days to just 21 working days. Companies involved in natural ingredient trade, formulation, and supply to the Brazilian market — particularly those sourcing from or operating in China — should assess operational implications closely.

Event Overview

On May 4, 2026, ANVISA officially initiated the ‘Natural Ingredients Fast Track’ program. Under this program, applications for registration of natural ingredients — specifically plant extracts, natural flavors, and food-grade enzyme preparations — are eligible for expedited review if supported by study data generated at laboratories certified under the OECD Good Laboratory Practice (GLP) framework. The target review period is 21 working days. Seventeen GLP-certified laboratories in China have received pre-recognition from ANVISA and may submit data directly to the agency.

Impact on Specific Industry Segments

Direct Trade Enterprises

These include exporters and importers handling natural ingredients between China and Brazil. They are affected because the shortened registration window reduces time-to-market for new product entries — but only for ingredients backed by OECD GLP-compliant data. Impact manifests in faster customs clearance eligibility, lower holding costs for inventory awaiting approval, and tighter alignment requirements with lab documentation standards.

Raw Material Sourcing Firms

Firms procuring botanicals or enzymes for downstream formulation face revised due diligence needs. Since ANVISA now explicitly links fast-track eligibility to OECD GLP certification, sourcing decisions must increasingly consider whether suppliers engage GLP-recognized labs for stability, safety, or specification testing — not just ISO or local accreditation.

Manufacturers & Formulators

Companies developing dietary supplements, functional foods, or natural cosmetics for the Brazilian market may accelerate product launches — provided their ingredient dossiers meet the Fast Track criteria. However, impact is conditional: formulations using non-GLP-supported ingredients remain subject to standard 120-day timelines, creating potential bottlenecks in multi-ingredient products.

Supply Chain & Regulatory Support Providers

Third-party consultants, regulatory affairs agencies, and logistics partners supporting ANVISA submissions must update service offerings to verify GLP lab status, align dossier formatting with Fast Track requirements, and manage expectations around eligibility thresholds — especially where clients assume all ‘natural’ ingredients qualify automatically.

What Relevant Enterprises or Practitioners Should Focus On

Monitor official guidance on scope clarification

ANVISA has not yet published a definitive list of qualifying natural ingredients or clarified whether ‘natural flavors’ includes fermentation-derived or enzymatically modified variants. Stakeholders should track updates via ANVISA’s official notices and technical bulletins.

Verify GLP lab recognition status before submission

While 17 Chinese GLP labs are pre-recognized, recognition does not guarantee automatic acceptance of all studies. Submitters must confirm that the specific study type (e.g., toxicology, stability) falls within the lab’s OECD GLP scope — as verified by national competent authorities and accepted by ANVISA.

Distinguish policy intent from immediate applicability

The Fast Track is a procedural pathway, not a waiver of scientific or compliance requirements. Applications still require full dossier submission, including specifications, manufacturing process details, and safety rationale. A 21-day timeline applies only after complete, technically compliant dossiers are received.

Prepare documentation workflows aligned with GLP traceability

Enterprises should audit internal or supplier documentation practices to ensure raw data, audit reports, and certificate validity dates are readily retrievable and match OECD GLP reporting conventions — particularly for studies conducted prior to May 2026.

Editorial Perspective / Industry Observation

Observably, this initiative signals ANVISA’s strategic prioritization of regulatory efficiency for low-risk, well-characterized natural substances — rather than representing an across-the-board deregulation. Analysis shows it reflects growing alignment with international standards (OECD GLP), but also introduces a new layer of technical gatekeeping: eligibility hinges not on ingredient origin or function alone, but on the provenance and rigor of supporting data. From an industry perspective, it is best understood not as an immediate operational shortcut, but as a targeted incentive — one that rewards upstream investment in internationally recognized quality infrastructure. Continued attention is warranted as ANVISA refines implementation protocols and publishes early case outcomes.

Conclusion
This Fast Track does not alter Brazil’s core safety or quality requirements for natural ingredients; instead, it restructures how compliance evidence is evaluated and processed. It is more accurately interpreted as a procedural optimization for a defined subset of ingredients — contingent on verifiable OECD GLP data — rather than a broad liberalization of import controls. Current readiness depends less on speed of application and more on precision of preparation.

Information Sources
Primary source: Official announcement issued by ANVISA on May 4, 2026.
Note: Implementation details — including application templates, eligibility checklists, and first-cycle performance metrics — remain pending publication and are subject to ongoing observation.